University of Texas-Arlington: Novel Therapy Could Reduce Risk of Bone Fracture
November 09, 2021
November 09, 2021
ARLINGTON, Texas, Nov. 9 (TNSJou) -- The University of Texas Arlington campus issued the following news release:
* * *
For those with diabetes, hepatocyte growth factor could improve bone health
* * *
Hepatocyte growth factor (HGF) could reduce the risk of bone fracture for people living with type 2 diabetes and hypertension, according to a new study from an international team of researchers at The University of Texas at Arlington and the Unive . . .
* * *
For those with diabetes, hepatocyte growth factor could improve bone health
* * *
Hepatocyte growth factor (HGF) could reduce the risk of bone fracture for people living with type 2 diabetes and hypertension, according to a new study from an international team of researchers at The University of Texas at Arlington and the Unive . . .